Schapira AH - Search Results

1

No evidence for substrate accumulation in Parkinson brains with GBA mutations.

Gegg ME, Sweet L, Wang BH, Shihabuddin LS, Sardi SP, Schapira AH. Gegg ME, et al. Among authors: schapira ah. Mov Disord. 2015 Jul;30(8):1085-9. doi: 10.1002/mds.26278. Epub 2015 Jun 11. Mov Disord. 2015. PMID: 26096906 Free PMC article.

2

Future directions in the treatment of Parkinson's disease.

Schapira AH. Schapira AH. Mov Disord. 2007 Sep;22 Suppl 17:S385-91. doi: 10.1002/mds.21679. Mov Disord. 2007. PMID: 18175401 Review.

3

The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease.

Schapira AH. Schapira AH. Mov Disord. 2008;23 Suppl 3:S515-20. doi: 10.1002/mds.22146. Mov Disord. 2008. PMID: 18781678

4

Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.

Gegg ME, Cooper JM, Schapira AH, Taanman JW. Gegg ME, et al. Among authors: schapira ah. PLoS One. 2009;4(3):e4756. doi: 10.1371/journal.pone.0004756. Epub 2009 Mar 9. PLoS One. 2009. PMID: 19270741 Free PMC article.

5

Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

Grünewald A, Gegg ME, Taanman JW, King RH, Kock N, Klein C, Schapira AH. Grünewald A, et al. Among authors: schapira ah. Exp Neurol. 2009 Sep;219(1):266-73. doi: 10.1016/j.expneurol.2009.05.027. Epub 2009 Jun 3. Exp Neurol. 2009. PMID: 19500570

6

Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study.

Schapira AH, Albrecht S, Barone P, Comella CL, McDermott MP, Mizuno Y, Poewe W, Rascol O, Marek K. Schapira AH, et al. Mov Disord. 2010 Aug 15;25(11):1627-32. doi: 10.1002/mds.23143. Mov Disord. 2010. PMID: 20544810 Clinical Trial.

7

Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, Taanman JW. Gegg ME, et al. Among authors: schapira ah. Hum Mol Genet. 2010 Dec 15;19(24):4861-70. doi: 10.1093/hmg/ddq419. Epub 2010 Sep 24. Hum Mol Genet. 2010. PMID: 20871098 Free PMC article.

8

PINK1-parkin-dependent mitophagy involves ubiquitination of mitofusins 1 and 2: Implications for Parkinson disease pathogenesis.

Gegg ME, Schapira AH. Gegg ME, et al. Among authors: schapira ah. Autophagy. 2011 Feb;7(2):243-5. doi: 10.4161/auto.7.2.14332. Epub 2011 Feb 1. Autophagy. 2011. PMID: 21139416 Free PMC article.

9

Mitochondrial contribution to Parkinson's disease pathogenesis.

Schapira AH, Gegg M. Schapira AH, et al. Parkinsons Dis. 2011;2011:159160. doi: 10.4061/2011/159160. Epub 2011 Apr 28. Parkinsons Dis. 2011. PMID: 21687805 Free PMC article.

10

Hyposmia and cognitive impairment in Gaucher disease patients and carriers.

McNeill A, Duran R, Proukakis C, Bras J, Hughes D, Mehta A, Hardy J, Wood NW, Schapira AH. McNeill A, et al. Among authors: schapira ah. Mov Disord. 2012 Apr;27(4):526-32. doi: 10.1002/mds.24945. Epub 2012 Feb 16. Mov Disord. 2012. PMID: 22344629 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters